ELM1 Is Required for Multidrug Resistance in Saccharomyces cerevisiae

In Saccharomyces cerevisiae, transcription of several drug transporter genes, including the major transporter gene PDR5, has been shown to peak during mitosis. The significance of this observation, however, remains unclear. PDR1 encodes the primary transcription activator of multiple drug transporter genes in S. cerevisiae, including PDR5. Here, we show that in synchronized PDR1 and pdr1-3 (multidrug resistant) strains, cellular efflux of a known substrate of ATP-binding-cassette transporters, doxorubicin (a fluorescent anticancer drug), is highest during mitosis when PDR5 transcription peaks. A genetic screen performed to identify regulators of multidrug resistance revealed that a truncation mutation in ELM1 (elm1-300) suppressed the multidrug resistance of pdr1-3. ELM1 encodes a serine/threonine protein kinase required for proper regulation of multiple cellular kinases, including those involved in mitosis, cytokinesis, and cellular morphogenesis. elm1-300 as well as elm1Δ mutations in a pdr1-3 strain also caused elongated bud morphology (indicating a G2/M delay) and reduction of PDR5 transcription under induced and noninduced conditions. Interestingly, mutations in several genes functionally related to ELM1, including cla4Δ, gin4Δ, and cdc28-C127Y, also caused drastic reductions in drug resistance and PDR5 transcription. Collectively, these data show that ELM1, and genes encoding related serine/threonine protein kinases, are required for regulation of multidrug resistance involving, at least in part, control of PDR5 transcription.

[1]  H. Jungwirth,et al.  Yeast ABC transporters – A tale of sex, stress, drugs and aging , 2006, FEBS letters.

[2]  J. Bähler Cell-cycle control of gene expression in budding and fission yeast. , 2005, Annual review of genetics.

[3]  Chen Gao,et al.  TFIID and Spt-Ada-Gcn5-Acetyltransferase Functions Probed by Genome-wide Synthetic Genetic Array Analysis Using a Saccharomyces cerevisiae taf9-ts Allele , 2005, Genetics.

[4]  Steven P. Gygi,et al.  Cdk1-Dependent Regulation of the Mitotic Inhibitor Wee1 , 2005, Cell.

[5]  R. Vishwakarma,et al.  Functional Analysis of CaIPT1, a Sphingolipid Biosynthetic Gene Involved in Multidrug Resistance and Morphogenesis of Candida albicans , 2005, Antimicrobial Agents and Chemotherapy.

[6]  C. Allis,et al.  RNA meets chromatin. , 2005, Genes & development.

[7]  Jung-Eun Park,et al.  Concerted mechanism of Swe1/Wee1 regulation by multiple kinases in budding yeast , 2005, The EMBO journal.

[8]  Curt Wittenberg,et al.  Cell cycle-dependent transcription in yeast: promoters, transcription factors, and transcriptomes , 2005, Oncogene.

[9]  G. Eytan Mechanism of multidrug resistance in relation to passive membrane permeation. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  I. Kovalszky,et al.  Antiproliferative and antimigratory effects of doxorubicin in human osteosarcoma cells exposed to extracellular matrix. , 2005, Anticancer research.

[11]  D. Bushnell,et al.  Structural basis of eukaryotic gene transcription , 2005, FEBS letters.

[12]  Chen Gao,et al.  On the Mechanism of Constitutive Pdr1 Activator-mediated PDR5 Transcription in Saccharomyces cerevisiae , 2004, Journal of Biological Chemistry.

[13]  Nicola J. Rinaldi,et al.  Transcriptional regulatory code of a eukaryotic genome , 2004, Nature.

[14]  D. Lew,et al.  Genetic Interactions among Regulators of Septin Organization , 2004, Eukaryotic Cell.

[15]  Jung-Eun Park,et al.  Coupling morphogenesis to mitotic entry , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Shokat,et al.  Targets of the cyclin-dependent kinase Cdk1 , 2003, Nature.

[17]  E. O’Shea,et al.  Global analysis of protein localization in budding yeast , 2003, Nature.

[18]  H. Penefsky,et al.  Immediate effects of anticancer drugs on mitochondrial oxygen consumption. , 2003, Biochemical pharmacology.

[19]  K. Kuchler,et al.  Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast. , 2003, International journal of antimicrobial agents.

[20]  Anthony C. Bishop,et al.  Specific Inhibition of Elm1 Kinase Activity Reveals Functions Required for Early G1 Events , 2003, Molecular and Cellular Biology.

[21]  D. Hardie,et al.  Elm1p Is One of Three Upstream Kinases for the Saccharomyces cerevisiae SNF1 Complex , 2003, Current Biology.

[22]  A. Myers,et al.  Assembly interdependence among the S. cerevisiae bud neck ring proteins Elm1p, Hsl1p and Cdc12p , 2003, Yeast.

[23]  David Carling,et al.  Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  F. Gorelick,et al.  Pancreas Cell Physiology and Pancreatitis Cell Biology , 2003, Pancreatology.

[25]  P. Piper,et al.  War1p, a Novel Transcription Factor Controlling Weak Acid Stress Response in Yeast , 2003, Molecular and Cellular Biology.

[26]  M. Gottesman,et al.  Studies with Novel Pdr5p Substrates Demonstrate a Strong Size Dependence for Xenobiotic Efflux* , 2003, The Journal of Biological Chemistry.

[27]  Rudy Pandjaitan,et al.  The yeast zinc finger regulators Pdr1p and Pdr3p control pleiotropic drug resistance (PDR) as homo‐ and heterodimers in vivo , 2002, Molecular microbiology.

[28]  M. Gerstein,et al.  Complex transcriptional circuitry at the G1/S transition in Saccharomyces cerevisiae. , 2002, Genes & development.

[29]  R. Ashery-Padan Somatic gene targeting in the developing and adult mouse retina. , 2002, Methods.

[30]  Chandra L. Theesfeld,et al.  Determinants of Swe1p degradation in Saccharomyces cerevisiae. , 2002, Molecular biology of the cell.

[31]  Kerby Shedden,et al.  Analysis of cell-cycle gene expression in Saccharomyces cerevisiae using microarrays and multiple synchronization methods , 2002, Nucleic Acids Res..

[32]  A. Goffeau,et al.  Functional dissection of Pdr1p, a regulator of multidrug resistance in Saccharomyces cerevisiae , 2002, Molecular Genetics and Genomics.

[33]  K. Nakai,et al.  Sequence-based approach for identification of cell wall proteins in Saccharomyces cerevisiae , 2002, Current Genetics.

[34]  Gary D Bader,et al.  Systematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants , 2001, Science.

[35]  S. Pennings,et al.  Antagonistic remodelling by Swi–Snf and Tup1–Ssn6 of an extensive chromatin region forms the background for FLO1 gene regulation , 2001, The EMBO journal.

[36]  F. Sharom,et al.  Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter. , 2001, Biochemistry.

[37]  David Y. Thomas,et al.  Htm1p, a mannosidase‐like protein, is involved in glycoprotein degradation in yeast , 2001, EMBO reports.

[38]  K. Lewis In search of natural substrates and inhibitors of MDR pumps. , 2001, Journal of molecular microbiology and biotechnology.

[39]  K. Kuchler,et al.  Fungal ABC proteins: pleiotropic drug resistance, stress response and cellular detoxification. , 2001, Research in microbiology.

[40]  A. Goffeau,et al.  The pleitropic drug ABC transporters from Saccharomyces cerevisiae. , 2001, Journal of molecular microbiology and biotechnology.

[41]  A. Goffeau,et al.  Protein kinase C effectors bind to multidrug ABC transporters and inhibit their activity. , 2001, Biochemistry.

[42]  D. Botstein,et al.  Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF , 2001, Nature.

[43]  T. Hallstrom,et al.  Multiple Signals from Dysfunctional Mitochondria Activate the Pleiotropic Drug Resistance Pathway in Saccharomyces cerevisiae* , 2000, The Journal of Biological Chemistry.

[44]  Joseph Heitman,et al.  Sok2 Regulates Yeast Pseudohyphal Differentiation via a Transcription Factor Cascade That Regulates Cell-Cell Adhesion , 2000, Molecular and Cellular Biology.

[45]  V. Ling,et al.  Cell‐cycle–dependent turnover of P‐glycoprotein in multidrug‐resistant cells , 2000, Journal of cellular physiology.

[46]  Chandra L. Theesfeld,et al.  Septin-Dependent Assembly of a Cell Cycle-Regulatory Module in Saccharomyces cerevisiae , 2000, Molecular and Cellular Biology.

[47]  C Mann,et al.  Regulation of cytokinesis by the Elm1 protein kinase in Saccharomyces cerevisiae. , 2000, Journal of cell science.

[48]  A. Goffeau,et al.  Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants , 2000, FEBS letters.

[49]  K. Kuchler,et al.  The transmembrane domain 10 of the yeast Pdr5p ABC antifungal efflux pump determines both substrate specificity and inhibitor susceptibility , 2000, Molecular microbiology.

[50]  K. Kuchler,et al.  Inventory and function of yeast ABC proteins: about sex, stress, pleiotropic drug and heavy metal resistance. , 1999, Biochimica et biophysica acta.

[51]  D. Kellogg,et al.  The Elm1 Kinase Functions in a Mitotic Signaling Network in Budding Yeast , 1999, Molecular and Cellular Biology.

[52]  R. Poon,et al.  G1 versus G2 cell cycle arrest after adriamycin‐induced damage in mouse Swiss3T3 cells , 1999, FEBS letters.

[53]  D. Lew,et al.  Phosphorylation-Independent Inhibition of Cdc28p by the Tyrosine Kinase Swe1p in the Morphogenesis Checkpoint , 1999, Molecular and Cellular Biology.

[54]  F. Innocenti,et al.  An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma. , 1999, Therapeutic drug monitoring.

[55]  A. Myers,et al.  Control of Saccharomyces cerevisiaeFilamentous Growth by Cyclin-Dependent Kinase Cdc28 , 1999, Molecular and Cellular Biology.

[56]  M. Mendenhall,et al.  Regulation of Cdc28 Cyclin-Dependent Protein Kinase Activity during the Cell Cycle of the Yeast Saccharomyces cerevisiae , 1998, Microbiology and Molecular Biology Reviews.

[57]  Michael Ruogu Zhang,et al.  Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. , 1998, Molecular biology of the cell.

[58]  Michael R. Green,et al.  Dissecting the Regulatory Circuitry of a Eukaryotic Genome , 1998, Cell.

[59]  Christopher W Carroll,et al.  The Septins Are Required for the Mitosis-specific Activation of the Gin4 Kinase , 1998, The Journal of cell biology.

[60]  Rudy Pandjaitan,et al.  The Pdr12 ABC transporter is required for the development of weak organic acid resistance in yeast , 1998, The EMBO journal.

[61]  P. Philippsen,et al.  Additional modules for versatile and economical PCR‐based gene deletion and modification in Saccharomyces cerevisiae , 1998, Yeast.

[62]  R. Kriwacki,et al.  Repression of TFIIH Transcriptional Activity and TFIIH-Associated cdk7 Kinase Activity at Mitosis , 1998, Molecular and Cellular Biology.

[63]  K. Kuchler,et al.  Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter. , 1998, Molecular biology of the cell.

[64]  K. Kuchler,et al.  The yeast ATP binding cassette (ABC) protein genes PDR10 and PDR15 are novel targets for the Pdr1 and Pdr3 transcriptional regulators , 1997, FEBS letters.

[65]  J. Garrett The control of morphogenesis in Saccharomyces cerevisiae by Elm1 kinase is responsive to RAS/cAMP pathway activity and tryptophan availability , 1997, Molecular microbiology.

[66]  A. Goffeau,et al.  Molecular and phenotypic characterization of yeast PDR1 mutants that show hyperactive transcription of various ABC multidrug transporter genes , 1997, Molecular and General Genetics MGG.

[67]  C. Jacq,et al.  Clustered amino acid substitutions in the yeast transcription regulator Pdr3p increase pleiotropic drug resistance and identify a new central regulatory domain , 1997, Molecular and General Genetics MGG.

[68]  F. Cross,et al.  Cla4p, a Saccharomyces cerevisiae Cdc42p-activated kinase involved in cytokinesis, is activated at mitosis , 1997, Molecular and cellular biology.

[69]  S. Ambudkar,et al.  Relation Between the Turnover Number for Vinblastine Transport and for Vinblastine-stimulated ATP Hydrolysis by Human P-glycoprotein* , 1997, The Journal of Biological Chemistry.

[70]  Michael R. Green,et al.  Yeast TAFII145 Functions as a Core Promoter Selectivity Factor, Not a General Coactivator , 1997, Cell.

[71]  Michael R. Green,et al.  Yeast TAFII145 Required for Transcription of G1/S Cyclin Genes and Regulated by the Cellular Growth State , 1997, Cell.

[72]  K. Kuchler,et al.  Plasma Membrane Translocation of Fluorescent-labeled Phosphatidylethanolamine Is Controlled by Transcription Regulators, PDR1 and PDR3 , 1997, The Journal of cell biology.

[73]  R. Altman,et al.  Control of Mitotic Events by Nap1 and the Gin4 Kinase , 1997, The Journal of cell biology.

[74]  D. Forbes,et al.  Mitotic repression of the transcriptional machinery. , 1997, Trends in biochemical sciences.

[75]  A. Myers,et al.  Serine‐threonine protein kinase activity of Elm1p, a regulator of morphologic differentiation in Saccharomyces cerevisiae , 1997, FEBS letters.

[76]  O Poch,et al.  Conservation of a putative inhibitory domain in the GAL4 family members. , 1997, Gene.

[77]  M. Kołaczkowski,et al.  Anticancer Drugs, Ionophoric Peptides, and Steroids as Substrates of the Yeast Multidrug Transporter Pdr5p* , 1996, The Journal of Biological Chemistry.

[78]  D. Lew,et al.  Cdc28 tyrosine phosphorylation and the morphogenesis checkpoint in budding yeast. , 1996, Molecular biology of the cell.

[79]  T. Hallstrom,et al.  Multiple Pdr1p/Pdr3p Binding Sites Are Essential for Normal Expression of the ATP Binding Cassette Transporter Protein-encoding Gene PDR5* , 1996, The Journal of Biological Chemistry.

[80]  M. Boiocchi,et al.  Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line. , 1996, European journal of cancer.

[81]  R. Perez-soler,et al.  Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. , 1996, Molecular pharmacology.

[82]  K. Kuchler,et al.  The yeast multidrug transporter Pdr5 of the plasma membrane is ubiquitinated prior to endocytosis and degradation in the vacuole , 1996, FEBS letters.

[83]  C. Jacq,et al.  Positive autoregulation of the yeast transcription factor Pdr3p, which is involved in control of drug resistance , 1995, Molecular and cellular biology.

[84]  A. Goffeau,et al.  Yeast multidrug resistance: The PDR network , 1995, Journal of bioenergetics and biomembranes.

[85]  C. Jacq,et al.  PDR3, a new yeast regulatory gene, is homologous toPDR1 and controls the multidrug resistance phenomenon , 1994, Molecular and General Genetics MGG.

[86]  S. G. Coats,et al.  Regulation of dimorphism in Saccharomyces cerevisiae: involvement of the novel protein kinase homolog Elm1p and protein phosphatase 2A , 1993, Molecular and cellular biology.

[87]  A. Goffeau,et al.  Interaction of the yeast pleiotropic drug resistance genes PDR1 and PDR5 , 1992, Current Genetics.

[88]  Ellson Y. Chen,et al.  Overview of manual and automated DNA sequencing by the dideoxy chain termination method , 1991 .

[89]  M. Johnston,et al.  Phosphorylated forms of GAL4 are correlated with ability to activate transcription , 1990, Molecular and cellular biology.

[90]  R. Sikorski,et al.  A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. , 1989, Genetics.

[91]  W. Moye-Rowley Transcriptional control of multidrug resistance in the yeast Saccharomyces. , 2003, Progress in nucleic acid research and molecular biology.

[92]  M. Carlson,et al.  Supplemental Data LKB 1 Is the Upstream Kinase in the AMP-Activated Protein Kinase Cascade , 2003 .

[93]  A. Amon Synchronization procedures. , 2002, Methods in enzymology.

[94]  A. Goffeau,et al.  In vivo characterization of the drug resistance profile of the major ABC transporters and other components of the yeast pleiotropic drug resistance network. , 1998, Microbial drug resistance.

[95]  I. Pastan,et al.  Genetic analysis of the multidrug transporter. , 1995, Annual review of genetics.

[96]  F. Sherman Getting started with yeast. , 1991, Methods in enzymology.

[97]  C. Lawrence Classical mutagenesis techniques. , 1991, Methods in enzymology.